← Back to headlines
Adicet Bio Secures FDA Clearance for Prostate Cancer Clinical Trial
Gene therapy company Adicet Bio has received regulatory approval from the FDA to proceed with a clinical trial evaluating its experimental treatment for prostate cancer.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
